BioGaia Logo

BioGaia

Develops and commercializes clinically proven probiotics for digestive health across all life stages.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0017769987 (+1 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioGaia is a biotechnology company specializing in the research, development, and commercialization of probiotic products. Since its founding in 1990, the company has focused on developing clinically proven probiotics to support digestive health and overall well-being for all life stages. Its product portfolio is based on patented strains of Lactobacillus, with key offerings like the BioGaia Protectis® line. This includes probiotic drops for infants, which are researched to help with common digestive issues such as colic, constipation, and diarrhea. BioGaia positions itself as a science-driven leader in its field, providing products that help maintain a healthy intestinal microflora.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioGaia and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 17:30
Post-Annual General Meeting Information
Extra bolagsstämma i BioGaia
Swedish 149.3 KB
2025-08-22 17:30
Board/Management Information
Extraordinary General Meeting of BioGaia
English 71.0 KB
2025-07-25 09:31
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i BioGaia AB (publ)
Swedish 169.8 KB
2025-07-25 09:31
Pre-Annual General Meeting Information
Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)
English 199.0 KB
2025-07-18 08:01
Interim Report
Swedish 20.6 MB
2025-07-18 08:01
Interim Report
English 18.4 MB
2025-06-18 14:20
Major Shareholding Notification
Swedish 10.0 KB
2025-05-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Förändrat antal röster i BioGaia AB (publ)
Swedish 261.2 KB
2025-05-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Change in the number of votes in BioGaia AB (publ)
English 231.4 KB
2025-05-21 14:04
Declaration of Voting Results & Voting Rights Announcements
Swedish 10.0 KB
2025-05-20 13:01
Major Shareholding Notification
Swedish 10.7 KB
2025-05-14 16:43
Declaration of Voting Results & Voting Rights Announcements
Swedish 10.0 KB
2025-05-12 16:39
Major Shareholding Notification
Swedish 10.0 KB
2025-05-07 18:30
Post-Annual General Meeting Information
Annual General Meeting of BioGaia
English 88.0 KB
2025-05-07 18:30
Post-Annual General Meeting Information
Årsstämma i BioGaia
Swedish 134.6 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

Company Country Ticker View
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
Develops vaccines and specialty medicines for infectious diseases, HIV, oncology, and immunology.
United Kingdom GSK
GNI  Group Ltd. Logo Japan 2160
Gour Medical Logo
Developed veterinary diagnostics and treatments for companion and production animals.
France MLGML
Grifols S.A. Logo
Develops plasma-derived medicines & biopharma solutions for rare and chronic conditions.
Spain GRF
Grindeks Logo
Pharmaceutical company developing and selling original/generic drugs & APIs globally.
Latvia GRD1R
Haemato AG Logo
Manufacturer & wholesaler of specialty pharma for chronic diseases & aesthetics.
Germany HAEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.